AUG 31, 2017 12:38 PM PDT

Two Immune Cell Types Accidentally Promote Heart Disease

WRITTEN BY: Kara Marker

Prescribing drugs that lower “bad” cholesterol is a common approach to treating heart disease, but scientists from the Karolinska Institute think there may be another solution.

Histopathology of atherosclerosis. Credit: Wikimedia User Pathos

Atherosclerosis, a disease characterized by the development of plaques in blood vessels that impede blood flow, is a common marker of heart disease. Immune cells called T cells and dendritic cells are regular occupiers of atherosclerotic plaques, where a collection of these cells and other debris floating through blood vessels ultimately pack together and block the flow of oxygenated blood to the heart. By targeting these immune cells, Karolinska Institute scientists believe they could develop a method for treating heart disease completely separate from techniques focused on lowering low-density lipoprotein (LDL), AKA “bad” cholesterol.

The main “ingredient” of this new technique is a protein called PCSK9 (proprotein convertase subtilisin kexin 9). PCSK9 proteins degrade LDL receptors, which results in increased amounts of LDL. Thus, PCSK9 inhibitors are prescribed to lower LDL cholesterol. But there’s yet another use for PCSK9 inhibitors.

The scientists needed to find a way to inhibit immune cells promoting the formation of atherosclerotic plaques without suppressing the entire immune system. So, they needed to know what specifically activates the T cells and dendritic cells found in atherosclerotic plaques. They discovered two key players: PCSK9 and oxidized LDL.

When LDL becomes oxidized, a modification is made to the lipoprotein that promotes its interaction with and uptake by macrophages, making oxidized LDL a clear marker for cardiovascular disease.

Researchers collected T cells from carotid arteries from people with atherosclerosis and from healthy individuals. Dendritic cells were taken from human peripheral blood. They combined dendritic cells with oxidized LDL before adding in T cells.

They found that oxidized LDL both triggered production of PCSK9 proteins and induced dendritic cell maturation and T cell activation into helper cells. However, inhibiting PCSK9 reversed the effects.

“This changed a pro-inflammatory profile into an anti-inflammatory state that is potentially anti-atherosclerotic,” explained lead author Prof Johan Frostegård. “The benefits of PCSK9 inhibition extend beyond lowering LDL cholesterol.”

Source: Methods in Molecular Biology, European Society of Cardiology

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 05, 2018
Cardiology
JUL 05, 2018
Stem Cell Treatment Restores Failing Macaque Monkey Hearts
A new way to prevent heart attack from turning into heart failure relies on heart cells made from human embryonic stem cells. For now, researchers are test...
JUL 29, 2018
Cardiology
JUL 29, 2018
Gender Disparity in Post Heart Attack Treatment
Death rates and adverse cardiovascular events twice as likely in women after experiencing STEMI heart attack compared to men....
AUG 16, 2018
Cardiology
AUG 16, 2018
Binge Drinking and the Heart
You might want to consider your heart when you go out drinking, binge drinking may cause increased cardiovascular risk....
AUG 28, 2018
Drug Discovery
AUG 28, 2018
Drug Reduced Recurrent Ventricular Tachycardia
A common drug used to treat chest pain, known as ranolazine and branded as Ranexa®, was found to be safe in a clinical study of more than 1,000 patient...
AUG 31, 2018
Health & Medicine
AUG 31, 2018
Should the FDA Tighten Regulations on Vaping Products?
The use of E-cigarettes, or vape pens, has skyrocketed among young people. Despite federal laws that mandate customers be at least 18 years of age to purch...
SEP 23, 2018
Cardiology
SEP 23, 2018
Take Control of Your Heart Data With Apple's New Watch
      Consumer grade activity trackers have been steadily increasing in popularity in recent years. Although these wearables initially were...
Loading Comments...